Full Year 2020 Results


FY 2020 Presentation

FY 2020 Presentation Final

FY 2020 Key Stats

€66.7m
EBITDA
6.7%
Organic GP Growth YoY
18.9%
ROCE 2020
12.6c
Adjusted EPS

Group Highlights

€217.3m

2020 GP

Employees
Partnering with 7 of the top 10 pharma companies
and 7 of the top 10 medical device companies